DE2234255C3 - Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel - Google Patents

Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel

Info

Publication number
DE2234255C3
DE2234255C3 DE2234255A DE2234255A DE2234255C3 DE 2234255 C3 DE2234255 C3 DE 2234255C3 DE 2234255 A DE2234255 A DE 2234255A DE 2234255 A DE2234255 A DE 2234255A DE 2234255 C3 DE2234255 C3 DE 2234255C3
Authority
DE
Germany
Prior art keywords
carbon atoms
carboxylic acid
acid
mixture
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2234255A
Other languages
German (de)
English (en)
Other versions
DE2234255B2 (de
DE2234255A1 (de
Inventor
John H. Fried
Ian T. Harrison
Jurg R. Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of DE2234255A1 publication Critical patent/DE2234255A1/de
Publication of DE2234255B2 publication Critical patent/DE2234255B2/de
Application granted granted Critical
Publication of DE2234255C3 publication Critical patent/DE2234255C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE2234255A 1971-08-23 1972-07-12 Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel Expired DE2234255C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00174261A US3801598A (en) 1971-08-23 1971-08-23 Substituted xanthone carboxylic acid compounds

Publications (3)

Publication Number Publication Date
DE2234255A1 DE2234255A1 (de) 1973-03-08
DE2234255B2 DE2234255B2 (de) 1979-06-13
DE2234255C3 true DE2234255C3 (de) 1980-02-14

Family

ID=22635489

Family Applications (3)

Application Number Title Priority Date Filing Date
DE2234255A Expired DE2234255C3 (de) 1971-08-23 1972-07-12 Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DE2265113A Expired DE2265113C3 (de) 1971-08-23 1972-07-12 7-Chlorsulfonylxanthon-2-carbonsäure und Verfahren zu ihrer Herstellung
DE19722265052 Pending DE2265052A1 (de) 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureamide

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE2265113A Expired DE2265113C3 (de) 1971-08-23 1972-07-12 7-Chlorsulfonylxanthon-2-carbonsäure und Verfahren zu ihrer Herstellung
DE19722265052 Pending DE2265052A1 (de) 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureamide

Country Status (21)

Country Link
US (2) US3801598A (Direct)
JP (2) JPS5344472B2 (Direct)
AR (3) AR206284A1 (Direct)
AT (3) AT325043B (Direct)
AU (1) AU470740B2 (Direct)
BE (1) BE787843A (Direct)
CA (2) CA1023752A (Direct)
CH (1) CH585218A5 (Direct)
DE (3) DE2234255C3 (Direct)
DK (2) DK52675A (Direct)
ES (6) ES404788A1 (Direct)
FI (2) FI780958A7 (Direct)
FR (1) FR2150308B1 (Direct)
GB (4) GB1398100A (Direct)
HK (1) HK26576A (Direct)
IL (1) IL39885A (Direct)
MY (1) MY7600087A (Direct)
NL (1) NL7209618A (Direct)
NO (4) NO137198C (Direct)
SE (2) SE387944B (Direct)
ZA (1) ZA724754B (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919211A (en) * 1973-02-12 1975-11-11 American Home Prod 9-Oxoxanthene-N,N{40 -bis(substituted)-2,7-disulfonamides
IL47519A (en) * 1974-07-09 1979-03-12 Roussel Uclaf 7-sulphinimidoyl(sulphimidoyl)-xanthone-2-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
US4250097A (en) * 1978-03-08 1981-02-10 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
US4232040A (en) * 1978-03-08 1980-11-04 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
JPS5996856U (ja) * 1982-12-20 1984-06-30 日本電気株式会社 固体撮像装置
AU2014233555B2 (en) * 2007-05-10 2016-11-03 Dogwood Pharmaceuticals, Inc. Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi

Also Published As

Publication number Publication date
NO763176L (Direct) 1973-02-26
SE7510877L (sv) 1975-09-29
CA1023752A (en) 1978-01-03
DE2265113C3 (de) 1980-07-10
NO137201B (no) 1977-10-10
US3891766A (en) 1975-06-24
JPS5344472B2 (Direct) 1978-11-29
DK247676A (da) 1976-06-04
AR201284A1 (es) 1975-02-28
FI780958A7 (fi) 1978-03-29
AU470740B2 (en) 1976-03-25
IL39885A (en) 1976-01-30
AU4445772A (en) 1974-01-17
NO137198B (no) 1977-10-10
SE387944B (sv) 1976-09-20
AR206284A1 (es) 1976-07-15
CA1011747A (en) 1977-06-07
GB1398100A (en) 1975-06-18
ES435555A1 (es) 1977-07-01
ES435559A1 (es) 1976-12-16
GB1398096A (en) 1975-06-18
ES435558A1 (es) 1976-12-16
NO137198C (no) 1978-01-18
IL39885A0 (en) 1972-09-28
DE2234255B2 (de) 1979-06-13
ZA724754B (en) 1974-02-27
HK26576A (en) 1976-05-14
NO137202C (no) 1978-01-18
GB1398099A (en) 1975-06-18
MY7600087A (en) 1976-12-31
DE2234255A1 (de) 1973-03-08
ES435556A1 (es) 1976-12-16
JPS537674A (en) 1978-01-24
ES404788A1 (es) 1975-11-16
AR218596A1 (es) 1980-06-30
CH585218A5 (Direct) 1977-02-28
NO137597C (no) 1978-03-21
US3801598A (en) 1974-04-02
JPS4829778A (Direct) 1973-04-19
DK52675A (Direct) 1975-08-04
NL7209618A (Direct) 1973-02-27
AT320644B (de) 1975-02-25
AT325043B (de) 1975-09-25
BE787843A (fr) 1973-02-22
FR2150308B1 (Direct) 1976-07-02
ES435557A1 (es) 1976-12-16
NO137201C (no) 1978-01-18
DE2265113B2 (de) 1979-10-31
GB1398098A (en) 1975-06-18
FI783924A7 (fi) 1978-12-20
NO137597B (no) 1977-12-12
FR2150308A1 (Direct) 1973-04-06
AT325612B (de) 1975-10-27
NO137202B (no) 1977-10-10
DE2265113A1 (de) 1976-04-22
DE2265052A1 (de) 1976-01-08

Similar Documents

Publication Publication Date Title
DE2543249A1 (de) Phenylsulfinylphenylessigsaeuren, verfahren zu ihrer herstellung und diese enthaltende heilmittel
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE3317107A1 (de) Immunomodulierendes mittel
DE2362409B2 (de) NJ4'<m-Phenylen)-dioxamidsäuren und deren Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP0026876A1 (de) N-Phenoxyalkylpiperidin-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0025192A2 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DE2234255C3 (de) Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DE2931418C2 (Direct)
EP0046961B1 (de) Epoxi-cycloalkylalkancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie sie enthaltende Arzneimittel
DE68907095T2 (de) Verbindungen zur Verhinderung der Biosynthese von der Lipoxygenase abgeleiteten Metaboliten der Arachidonsäure.
EP0006114B1 (de) 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
EP0621037B1 (de) Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD251126A1 (de) Verfahren zur herstellung neuer 2-arylsulfonamido-benzo- und -acetophenone und deren oxime, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE2723051C3 (de) NKAcyO-p-amino-NMn-decyl- und n-tridecyl)-benzamide sowie diese enthaltende Arzneimittel
DE69028355T2 (de) 4,5-Dihydro-6H-imidazo[4,5,1-ij]chinolin-6-on-6-oxim-O-sulfonsäurederivate
DE2617955A1 (de) Neue l-substituierte -aroyl-4-hydroxypiperidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2936730A1 (de) Auronderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2344799A1 (de) Schwefelhaltige tricyclische verbindungen und diese enthaltende arzneimittel
DD154816B3 (de) Verfahren zur herstellung neuer pyridine
DE2248741C3 (de) 5-Phenoxy-und 5-Thlophenoxy-2(1 H)pyrimldinone
EP0147778A2 (de) 1,4-Naphthochinonderivate mit entzündungshemmender Wirkung
DE2829619A1 (de) Arzneimittel, enthaltend benzyliden- 2-benzofurane
EP0095641B1 (de) Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2804909A1 (de) Imidazo eckige klammer auf 1,5-b eckige klammer zu -pyridazine
EP0091045B1 (de) 2-Pyrrolin-3-carbonitril-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee